Alpine Immune Sciences, Inc.

NASDAQ:ALPN

64.97 (USD) • At close May 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 7.03230.85310.0438.5939.3872.7768.3675.29213.6294.538.5167.1933.2045.6431.9130.6881.0910.8840.2890.5670000.390.3150.1280.1280.7380.7370.7380.7370.7380.73700000000
Cost of Revenue 0.1470.1480.1460.1420.140.1450.1480.1560.1480.13818.30914.63410.4379.0556.1567.0964.8785.7999.53210.16610.358.93110.5295.7183.7923.712.752.3081.8581.350.8190.3990.42100000000
Gross Profit 6.88530.7059.8978.4519.2472.6318.2195.13613.4814.392-9.793-7.441-7.233-3.412-4.243-6.408-3.787-4.915-9.243-9.599-10.35-8.931-10.529-5.328-3.477-3.582-2.622-1.57-1.121-0.612-0.0820.3390.31600000000
Gross Profit Ratio 0.9790.9950.9850.9830.9850.9480.9820.9710.9890.97-1.15-1.034-2.257-0.605-2.218-9.314-3.471-5.56-31.983-16.929000-13.662-11.038-27.984-20.484-2.127-1.521-0.829-0.1110.4590.42900000000
Reseach & Development Expenses 22.3122.78419.1519.24119.58118.75617.58917.58716.31115.36218.30914.63410.4379.0556.1567.0964.8785.7999.53210.16610.358.93110.5295.7183.7923.712.750.3592.7585.6565.6696.4245.5674.2934.2794.4653.0162.8222.1643.3633.851
General & Administrative Expenses 7.2716.3745.4435.0075.3984.3894.614.1944.7754.5443.473.293.2563.0492.7283.3441.7782.1022.4672.5532.3452.5141.8571.8832.1081.2071.9322.5922.7812.1681.8792.1722.3672.3371.8221.3871.2980.6650.490.5940.539
Selling & Marketing Expenses 00000000000000000000000000000000000000000
SG&A 7.2716.3745.4435.0075.3984.3894.614.1944.7754.5443.473.293.2563.0492.7283.3441.7782.1022.4672.5532.3452.5141.8571.8832.1081.2071.9322.5922.7812.1681.8792.1722.3672.3371.8221.3871.2980.6650.490.5940.539
Other Expenses -0.0030.501-0.063-0.001-0.022-0.0250-0.015-0.057-0.0040000.0431.037000.8120001.20301.2030000000000.0670.01200.00100.0350.0090.252
Operating Expenses 29.58129.15824.59324.24824.97923.14522.19921.78121.08619.90621.77917.92413.69312.1048.88410.446.6567.90111.99912.71912.69511.44512.3867.6015.94.9174.6822.9515.5397.8247.5488.5967.9346.636.1015.8524.3153.4862.6543.9574.39
Operating Income -22.6961.547-14.55-15.655-15.592-20.369-13.832-16.489-7.457-15.376-13.263-10.731-10.489-6.461-6.971-9.752-5.565-7.017-11.71-12.152-12.695-11.445-12.386-8.414-5.585-4.789-4.554-3.815-9.025-7.824-7.548-8.596-7.934-6.63-6.101-5.852-4.315-3.486-2.654-3.957-4.39
Operating Income Ratio -3.2280.05-1.449-1.822-1.661-7.338-1.653-3.116-0.547-3.394-1.557-1.492-3.274-1.145-3.644-14.174-5.101-7.938-40.519-21.432000-21.574-17.73-37.414-35.578-5.169-12.246-10.602-10.242-11.648-10.76500000000
Total Other Income Expenses Net 4.7784.516-0.063-0.0012.3262.0530.5590.169-0.066-0.004-0.151-0.167-0.1540.0431.037-0.1820.0320.8120.2350.2960.3140.2490.247-1.2030.2270.0626.539-0.864-3.4860.4390.1150.1170.0960.0670.01200.00100.0350.0090.252
Income Before Tax -17.9186.063-11.722-13.156-13.266-18.316-13.273-16.32-7.523-15.465-13.414-10.898-10.643-6.342-6.137-9.934-5.533-6.14-11.475-11.856-12.381-11.196-12.139-8.16-5.358-4.5222.126-3.71-8.916-7.713-7.433-8.479-7.838-6.563-6.089-5.852-4.314-3.486-3.011-4.189-4.35
Income Before Tax Ratio -2.5480.197-1.167-1.531-1.413-6.598-1.586-3.084-0.552-3.414-1.575-1.515-3.322-1.124-3.208-14.439-5.071-6.946-39.706-20.91000-20.923-17.01-35.32816.609-5.027-12.098-10.451-10.085-11.489-10.63500000000
Income Tax Expense 00.103-0.0630.027-2.2560.548-0.5591.7780.004-0.2980.080.1310.06301.251-0.0060.1521.528-0.0590.3570.079-0.0610.329-0.253-0.052-0.2040.0040.7593.320.28900-0.03-0.019-0.01600.00100.4270.250.465
Net Income -17.9185.96-11.722-13.156-11.01-18.864-12.714-18.098-7.527-15.167-13.494-11.029-10.643-6.342-6.137-9.928-5.533-6.14-11.475-11.856-12.381-11.135-12.139-7.907-5.306-4.3182.122-3.71-8.916-7.713-7.433-8.479-7.838-6.563-6.089-5.852-4.314-3.486-3.011-4.189-4.35
Net Income Ratio -2.5480.193-1.167-1.531-1.173-6.795-1.52-3.42-0.552-3.348-1.585-1.533-3.322-1.124-3.208-14.43-5.071-6.946-39.706-20.91000-20.274-16.844-33.73416.578-5.027-12.098-10.451-10.085-11.489-10.63500000000
EPS -0.280.099-0.24-0.27-0.23-0.41-0.4-0.6-0.25-0.52-0.55-0.46-0.45-0.27-0.28-0.53-0.3-0.33-0.62-0.64-0.7-0.63-0.88-0.57-0.38-0.310.2-0.95-2.28-1.99-12.21-2.19-2.03-1.7-1.58-5.63-1.29-1.53-1.32-1.84-1.91
EPS Diluted -0.280.099-0.24-0.27-0.23-0.41-0.4-0.6-0.25-0.52-0.55-0.46-0.45-0.27-0.28-0.53-0.3-0.33-0.62-0.64-0.7-0.63-0.88-0.57-0.38-0.310.18-0.95-2.28-1.99-12.21-2.19-2.03-1.7-1.58-5.63-1.29-1.53-1.32-1.84-1.91
EBITDA -22.5491.695-11.576-12.986-13.196-18.229-13.02-16.034-7.221-15.287-13.056-10.518-10.261-6.127-5.783-9.564-5.278-5.999-11.409-11.417-12.311-11.011-11.948-6.784-5.2-4.432-4.338-2.035-2.053-7.824-7.51-8.56-7.934-6.63-6.101-5.837-4.298-3.469-2.602-3.927-4.106
EBITDA Ratio -3.2070.055-1.153-1.511-1.406-6.567-1.556-3.03-0.53-3.375-1.533-1.462-3.203-1.086-3.023-13.901-4.838-6.786-39.478-20.136000-17.395-16.508-34.625-33.891-2.757-2.786-10.602-10.19-11.599-10.76500000000